Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Pfizer Inc. (PFE) shares rose 2.15% to $28.57, outperforming competitors Johnson & Johnson, Eli Lilly, and Abbott Laboratories on a favorable trading day. The stock closed near its 52-week high of $28.75. Trading volume was below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Pfizer Inc. (PFE) rose 2.15% to $28.57 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.32% to 7,677.28 and the Dow Jones Industrial Average rising 0.30% to 53,577.40.
Pfizer Inc. closed 0.61% below its 52-week high of $28.75, which the company achieved on April 2nd.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.53% to $273.14, Eli Lilly & Co. (LLY) fell 1.06% to $1,233.66, and Abbott Laboratories (ABT) fell 0.46% to $116.13.
Trading volume (30.9 M) remained 13.3 million below its 50-day average volume of 44.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-25-26 1637ET